2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) …
IC Van Gelder, M Rienstra, KV Bunting… - European Heart …, 2024 - academic.oup.com
• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …
off-label use of medication should be limited to situations where it is in the patient's interest …
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery …
MicroRNAs (miRNAs) are small regulatory molecules post-transcriptionally suppressing
mRNA activity. Many miRNAs in various organisms have been cloned but many unknown …
mRNA activity. Many miRNAs in various organisms have been cloned but many unknown …
Rivaroxaban is associated with higher rates of gastrointestinal bleeding than other direct oral anticoagulants: A nationwide propensity score–weighted study
Background: Gastrointestinal bleeding (GIB) rates for direct oral anticoagulants (DOACs)
and warfarin have been extensively compared. However, population-based studies …
and warfarin have been extensively compared. However, population-based studies …
Quality indicators for the care and outcomes of adults with atrial fibrillation: Task Force for the development of quality indicators in atrial fibrillation of the European …
Aims To develop quality indicators (QIs) that may be used to evaluate the quality of care and
outcomes for adults with atrial fibrillation (AF). Methods and results We followed the ESC …
outcomes for adults with atrial fibrillation (AF). Methods and results We followed the ESC …
Factor XI inhibitors for the prevention of cardiovascular disease: A new therapeutic approach on the horizon?
Anticoagulant drugs that are currently used to prevent and/or treat thrombosis have some
limitations that hinder their ability to meet specific clinical requirements. While these drugs …
limitations that hinder their ability to meet specific clinical requirements. While these drugs …
[PDF][PDF] Comparison of the real-life clinical outcomes of warfarin with effective time in therapeutic range and non-vitamin K antagonist oral anticoagulants: insight from …
Background: It is unclear whether warfarin treatment with high time in therapeutic range
(TTR) is as effective and safe as non-vitamin K antagonist oral anticoagulants (NOACs). It is …
(TTR) is as effective and safe as non-vitamin K antagonist oral anticoagulants (NOACs). It is …
Trends in incidence of intracerebral hemorrhage and association with antithrombotic drug use in Denmark, 2005-2018
SM Hald, S Möller, LAG Rodríguez… - JAMA network …, 2021 - jamanetwork.com
Importance Spontaneous (nontraumatic) intracerebral hemorrhage (ICH) is the most severe
complication of antithrombotic drug use. Objectives To estimate the strength of association …
complication of antithrombotic drug use. Objectives To estimate the strength of association …
Efficacy and safety of reduced-dose non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: a meta-analysis of randomized controlled trials
Aims Non-vitamin K antagonist oral anticoagulants (NOACs) require dose reductions
according to patient or clinical factors for patients with atrial fibrillation (AF). In this meta …
according to patient or clinical factors for patients with atrial fibrillation (AF). In this meta …
Effectiveness and safety of apixaban in over 3.9 million people with atrial fibrillation: a systematic review and meta-analysis
BJR Buckley, DA Lane, P Calvert, J Zhang… - Journal of clinical …, 2022 - mdpi.com
Background: There is a plethora of real-world data on the safety and effectiveness of direct-
acting oral anticoagulants (DOACs); however, study heterogeneity has contributed to …
acting oral anticoagulants (DOACs); however, study heterogeneity has contributed to …
Comparative effectiveness and safety of direct oral anticoagulants versus vitamin K antagonists in nonvalvular atrial fibrillation: a Canadian multicentre observational …
M Durand, ME Schnitzer, M Pang, G Carney… - … Open Access Journal, 2020 - cmajopen.ca
Background: Direct oral anticoagulants (DOACs) have widely replaced warfarin for stroke
prevention in nonvalvular atrial fibrillation. Our objective was to compare the safety and …
prevention in nonvalvular atrial fibrillation. Our objective was to compare the safety and …